AGC Inc to expand its biopharmaceutical CDMO capability in Japan
AGC Inc, Japan-headquartered manufacturer of glass, chemicals, and high-tech materials, has decided to expand its biopharmaceutical CDMO (contract development and manufacturing organisation) capability at the AGC Yokohama Technical Center. The total investment for the expansion is expected to be approximately 50 billi…
